Authorities from the German state of Hesse have taken aim at the practice of ‘GMP washing’ in its thriving medical cannabis market, an intervention that could have significant implications for the industry at large.
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year.
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global report produced in collaboration with Prohibition Partners, the industry-first discovery platform for B2B cannabis.
The Federal Institute for Drugs and Medical Devices (BfArM) has announced that Germany’s estimated annual demand for medical cannabis in 2025 has already been reached, leading to a temporary suspension of new import licences.
On 25 September, PTMC hosted its seventh edition in central Lisbon, amid a growing sense that Portugal’s medical cannabis sector has reached an inflection point.
In the latest instalment of our series spotlighting expert contributors to Prohibition Partners’ newly launched Insights Hub, we spoke with Terpene Belt Farms about how European cannabis brands can draw on the continent’s rich culinary and cultural traditions to build authentic, consumer-trusted products.
Below, we’ve summarised the key insights from the vibrant and diverse discussions throughout Day 2 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
